phenox GmbH

Introducing our member:

Company Profile Since its founding in 2005, phenox has been dedicated to developing groundbreaking and clinically validated technologies and solutions for the treatment of neurovascular diseases. phenox GmbH’s products are used by endovascular specialists to treat ischemic and hemorrhagic strokes. The company offers a growing portfolio of innovative treatment options—including technologies that have been proven effective over many years. The product lineup includes the pREset and pREset LITE mechanical thrombectomy systems, the p64 Flow Modulation Device for the treatment of complex intracranial aneurysms and dissections, and the pCONus implant, which was developed for the treatment of complex intracranial bifurcation aneurysms with a wide neck.